Steve O'Malley joins PriceSpective
This article was originally published in Scrip
Executive Summary
PriceSpective (US), an integrated value strategy consultancy providing pricing and reimbursement services to pharmaceutical and biotechnology companies, has appointed Steve O'Malley to lead its new payer engagement practice. He has more than 20 years' experience in the pharmaceutical industry, having previously served as vice-president of managed markets at Vertex Pharmaceuticals. Before that, he spent eight years at Amylin Pharmaceuticals, where he was executive director for payer and institutional marketing.